| Coronavirus (SARS-CoV-2) |
|
The 2019 novel coronavirus (SARS-CoV-2) which emerged in China presents a significant health threat in the Asia-Pacific region, and the ability to impact blood supply through donor deferrals, illness, quarantine and reduced staff or donor availability. This paper outlines key challenges and risks to assist blood sector preparedness, response and implementation of appropriate risk reduction strategies. |